Carrico Brian Allen 4

What Happened Brian Carrico, CEO of Neuraxis, was granted 94,173 restricted stock units (RSUs) on January 22, 2026. The award is reported at a per-share value of $4.63, with a total grant value of approximately $436,021. This was a compensation award (not an open-market purchase or sale).

Key Details

• Transaction date and type: 2026-01-22 — Grant/Award (code A) of 94,173 RSUs at $4.63 per share (total ~$436,021).
• Security: RSUs (derivative grant) — these are not immediately tradable shares; they convert to common stock upon vesting.
• Vesting: The RSUs vest in three equal annual installments over three years (per footnote).
• Shares owned after transaction: Not specified in the filing.
• Filing date/timeliness: Form 4 filed Feb 26, 2026 — this is more than two business days after the Jan 22 transaction and appears late under normal Form 4 timing rules.

Context RSU grants are a common form of executive compensation intended to align management incentives with shareholders; they do not represent an immediate cash purchase or sale and typically vest over time. Because these are restricted units with a multi-year vesting schedule, they do not necessarily signal an immediate change in the CEO’s market view.